Role of the NLRP3 inflammasome in gynecological disease

Biomed Pharmacother. 2023 Oct:166:115393. doi: 10.1016/j.biopha.2023.115393. Epub 2023 Sep 4.

Abstract

The NLR family pyrin domain containing 3 (NLRP3) inflammasome is involved in the innate immune system and is a three-part macromolecular complex comprising the NLRP3 protein, apoptosis-associated speck-like protein containing a CARD (ASC) and the cysteine protease pro-caspase-1. When the NLRP3 inflammasome is activated, it can produce interleukin (IL)- 1β and IL-18 and eventually lead to inflammatory cell pyroptosis. Related studies have demonstrated that the NLRP3 inflammasome can induce an immune response and is related to the occurrence and development of gynecological diseases, such as endometriosis, polycystic ovary syndrome and breast cancer. NLRP3 inflammasome inhibitors are beneficial for maintaining cellular homeostasis and tissue health and have been found effective in targeting some gynecological diseases. However, excessive inhibitor concentrations have been found to cause adverse effects. Therefore, proper control of NLRP3 inflammasome activity is critical. This paper summarizes the structure and function of the NLRP3 inflammasome and highlights the therapeutic potential of targeting it in gynecological diseases, such as endometriosis, polycystic ovary syndrome and breast cancer The application of NLRP3 inflammasome inhibitors is also discussed.

Keywords: Cancer; Gynecological diseases; Immunity; Inflammasome; Inflammasome inhibitors; NLRP3.

Publication types

  • Review

MeSH terms

  • Endometriosis* / drug therapy
  • Female
  • Genital Diseases, Female*
  • Humans
  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Polycystic Ovary Syndrome* / drug therapy

Substances

  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein